Cognoptix

Cognoptix is creating and developing a simple, innovative, non-invasive eye scanning test to help with the early detection and diagnosis of Alzheimer's disease. The key to effective prevention and treatment of Alzheimer's disease is to establish an "early warning system" for the disease before it progresses to a stage where treatment options are limited. Cognoptix's technology has demonstrated successful preclinical and clinical results as the company develops its diagnostic platform – a platform consisting of a laser eye scanner and an eye ointment that specifically identifies Alzheimer's-related proteins found in the eye.